As Novartis Eyes Growth in 2019, the Company Will Likely Cut Some Prices

Novartis Chief Executive Officer Vas Narasimhan said 2018 was a year of reimagining for Switzerland-based Novartis. It was a year when the company focused its capital and resourced on developing breakthrough medicines.